Favorite Annette F 4

What Happened Annette Favorite, Senior Vice President & Chief Human Resources Officer of West Pharmaceutical Services (WST), received two restricted stock unit (RSU) awards on March 1, 2026 totaling 2,432 RSUs (720 RSUs + 1,712 RSUs). The awards were granted at a $0.00 purchase price (award/derivative grants), so no cash was exchanged at grant. These are awards, not open-market purchases or sales.

Key Details

• Transaction date: March 1, 2026; Form 4 filed March 3, 2026 (timely filing).
• Grants: 720 RSUs and 1,712 RSUs; total = 2,432 RSUs; grant price recorded as $0.00.
• Shares owned after transaction: Not disclosed in the filing.
• Footnotes:
  • F1: Each RSU is a contingent right to receive one share of WST common stock.
  • F2: The RSUs vest in four equal annual installments beginning March 1, 2027.
• Transaction type: Award/Grant (derivative), code A.

Context RSUs are a form of equity compensation that convert into actual shares (or cash equivalent) only upon vesting; they do not represent immediate cash value or an open-market purchase. Because these RSUs vest over four years, any eventual shares (and their market value) will depend on WST’s stock price at vesting times. This filing reflects a routine equity grant to an executive and does not itself indicate a buy or sell market signal.